Second Sight Medical Products, Inc. (EYES)
(Delayed Data from NSDQ)
$0.99 USD
+0.01 (0.58%)
Updated May 3, 2019 04:00 PM ET
After-Market: $1.00 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
Vivani Medical, Inc. [EYES]
Reports for Purchase
Showing records 1 - 20 ( 49 total )
Company: Vivani Medical, Inc.
Industry: Medical - Instruments
Company: Vivani Medical, Inc.
Industry: Medical - Instruments
Company: Vivani Medical, Inc.
Industry: Medical - Instruments
Winding Down Operations; Revising Rating to Under Review From Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: DAYAL A
Company: Vivani Medical, Inc.
Industry: Medical - Instruments
Early Feasibility Study for Orion Complete; Revising Price Target to Reflect Reverse Split
Provider: H.C. Wainwright & Co., Inc.
Analyst: DAYAL A
Company: Vivani Medical, Inc.
Industry: Medical - Instruments
FDA Agreement on Orion Efficacy Endpoint Reached; 3Q19 Results Update
Provider: H.C. Wainwright & Co., Inc.
Analyst: DAYAL A
Company: Vivani Medical, Inc.
Industry: Medical - Instruments
Orion Discussions With FDA Ongoing; 2Q19 Results Update
Provider: H.C. Wainwright & Co., Inc.
Analyst: DAYAL A
Company: Vivani Medical, Inc.
Industry: Medical - Instruments
Company: Vivani Medical, Inc.
Industry: Medical - Instruments
Scaling Back Argus II And Better-Sighted RP Expectations; Lowering Price Target to $2.50
Provider: H.C. Wainwright & Co., Inc.
Analyst: DAYAL A
Company: Vivani Medical, Inc.
Industry: Medical - Instruments
Orion Feasibility Study Progresses; Steps Toward Strengthening Balance Sheet; Maintain Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: DAYAL A
Company: Vivani Medical, Inc.
Industry: Medical - Instruments
Orion Is Now Used by Patients at Home; 3Q18 Results Overview
Provider: H.C. Wainwright & Co., Inc.
Analyst: DAYAL A
Company: Vivani Medical, Inc.
Industry: Medical - Instruments
Company: Vivani Medical, Inc.
Industry: Medical - Instruments
Orion Data Is Big 2H18 Catalyst; Argus II Implants Steadier in US
Provider: H.C. Wainwright & Co., Inc.
Analyst: DAYAL A
Company: Vivani Medical, Inc.
Industry: Medical - Instruments
Strong 4Q17 Implants; Execution Around Key Catalysts Underway
Provider: H.C. Wainwright & Co., Inc.
Analyst: DAYAL A
Company: Vivani Medical, Inc.
Industry: Medical - Instruments
Orion Gets Go Ahead on Human Clinical Study; 3Q17 Results Overview; Affirm Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: DAYAL A
Company: Vivani Medical, Inc.
Industry: Medical - Instruments
German Study Toward Argus II Approval Progresses; Affirm Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: DAYAL A
Company: Vivani Medical, Inc.
Industry: Medical - Instruments
Orion Receives Conditional Approval for Feasibility Study; Affirm Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: DAYAL A
Company: Vivani Medical, Inc.
Industry: Medical - Instruments
Commercialization Execution Coming Through; Orion Related Catalysts Should Drive 2H17
Provider: Rodman & Renshaw, Co.
Analyst: DAYAL A
Company: Vivani Medical, Inc.
Industry: Medical - Instruments
Commercialization Execution Coming Through; Orion Related Catalysts Should Drive 2H17
Provider: H.C. Wainwright & Co., Inc.
Analyst: DAYAL A
Company: Vivani Medical, Inc.
Industry: Medical - Instruments
Expansion of Medicare Coverage in U.S. and Entry Into South Korean Market; Affirm Buy
Provider: Rodman & Renshaw, Co.
Analyst: DAYAL A
Company: Vivani Medical, Inc.
Industry: Medical - Instruments
Expansion of Medicare Coverage in U.S. and Entry Into South Korean Market; Affirm Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: DAYAL A